Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 14;12(9):e0183987.
doi: 10.1371/journal.pone.0183987. eCollection 2017.

IκK-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response

Affiliations

IκK-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response

Norman James Galbraith et al. PLoS One. .

Abstract

Excessive inflammatory responses in the surgical patient may result in cellular hypo-responsiveness, which is associated with an increased risk of secondary infection and death. microRNAs (miRNAs), such as miR-155, are powerful regulators of inflammatory signalling pathways including nuclear factor κB (NFκB). Our objective was to determine the effect of IκK-16, a selective blocker of inhibitor of kappa-B kinase (IκK), on miRNA expression and the monocyte inflammatory response. In a model of endotoxin tolerance using primary human monocytes, impaired monocytes had decreased p65 expression with suppressed TNF-α and IL-10 production (P < 0.05). miR-155 and miR-138 levels were significantly upregulated at 17 h in the impaired monocyte (P < 0.05). Notably, IκK-16 decreased miR-155 expression with a corresponding dose-dependent decrease in TNF-α and IL-10 production (P < 0.05), and impaired monocyte function was associated with increased miR-155 and miR-138 expression. In the context of IκK-16 inhibition, miR-155 mimics increased TNF-α production, while miR-155 antagomirs decreased both TNF-α and IL-10 production. These data demonstrate that IκK-16 treatment attenuates the monocyte inflammatory response, which may occur through a miR-155-mediated mechanism, and that IκK-16 is a promising approach to limit the magnitude of an excessive innate inflammatory response to LPS.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
(A) Supernatant TNF-α concentrations and (B) IL-10 concentrations comparing naïve (no LPS pre-treatment) and impaired (10 ng/mL LPS pre-treatment) conditions. Time points are shown for the end of the pre-treatment prior to the LPS challenge (17 h), and then the response 12 h after the LPS 100 ng/mL challenge (29 h). Levels were determined by ELISA. N = 8. Mean ± S.E.M. are shown. *P < 0.05, paired T-test. Time course of TNF-α (C) and IL-10 (D) gene expression in the impaired monocyte. Monocytes were treated with 10 ng/mL of LPS given after 1h for a duration of 16 h. At 17 h, cells were washed and resuspended in fresh media, then received 100 ng/mL of LPS at 17 h. Levels were measured by qRT-PCR, and expressed as fold change (2-ΔΔCT) relative to the naïve monocyte. Mean ± S.E.M. are shown. N = 4. *P < 0.05. # P = 0.09, paired T-test.
Fig 2
Fig 2. Expression of NFκB (p65) as measured by Western blot analysis.
Cells given pre-treatment at 1 h after isolation until 17 h, and then were washed, suspended in fresh media, and given a further treatment (challenge) for 60 min. Quantitative data are expressed as relative density units, using beta-actin as a loading control. Naïve conditions (media only / 100 ng/mL LPS) and impaired (10 ng/mL LPS / 100 ng/mL LPS) were compared by paired T-test. N = 6. Mean ± S.E.M. *P < 0.05.
Fig 3
Fig 3. Volcano plot showing toll-like receptor (TLR) gene expression profiles, expressed the impaired monocyte relative to the naïve monocyte.
Monocytes were cultured in media only (naïve) or 10 ng/mL LPS (impaired) until 17 h and then stimulated with an LPS 100 ng/mL challenge for 2 h. RNA was extracted from cell pellets, and 44 TLR genes were measured by qRT-PCR. Fold changes (FC) calculated by ΔΔCT method are expressed on the x-axis, with significance (-log10 p-value) demonstrated on the y-axis. Data were normalized to housekeeper genes 18S, GAPDH, and B2M. Green dots represent genes that are downregulated by a fold change of 0.66 (equivalent to fold regulation of -1.5). Dots in the blue boxes represent genes that were significantly dysregulated compared with the naïve monocyte (P < 0.05), paired T-test. N = 4. GAPDH = glyceraldehyde 3-phosphate dehydrogenase. B2M = beta-2 macroglobulin.
Fig 4
Fig 4. Volcano plot of miRNA screening of microRNA expression in the impaired monocyte relative to naïve conditions.
Monocytes were cultured in media only (naïve) or 10 ng/mL of LPS until 17 h. RNA was collected at 17 h, immediately prior to a 100 ng/mL LPS challenge. Data were normalized to housekeeping genes RNU6B, RNU44, and RNU48. Green dots represent miRNAs that were downregulated by a log2 fold change of -1.0. Red dots represent miRNA’s that were upregulated by a log2 fold change of +1.0. miRNAs in the blue boxes represent those that reached statistical significance (P < 0.01), paired T-test. N = 5.
Fig 5
Fig 5. Verification of miRNA differences in the impaired monocyte relative to naïve conditions at 17 h.
The most significant miRNAs selected from screening were used for single assay qRT-PCR confirmation. Data were normalized to RNU6B. N = 8. Mean ± S.E.M. *P < 0.05, paired T-test.
Fig 6
Fig 6
Effect of IκK-16 on miR-155 (A), SOCS1 (B) and SHP1 (C) expression. Monocytes were cultured with 100 nM of IκK-16 or DMSO (control) for 1 h and then 100 ng/mL of LPS was given for 17 h. Levels of miR-155, SOCS1, and SHP1 expression in IκK-16 treated monocytes are expressed as fold change relative to the DMSO (control) monocytes, as determined by qRT-PCR. MiRNA data were normalized to RNU6B, and mRNA data were normalized to 18S. Mean ± S.E.M. N = 6. * P<0.05, paired T-test. Western blot was similarly used determine protein levels at 17 h for SOCS1 (D) and SHP1 (E), with vinculin and beta-actin used as loading controls, respectively.
Fig 7
Fig 7. Effect of IκK-16 on cytokine production.
Monocytes were treated with DMSO (control) or IκK-16 for 1 h and then stimulated with 100 ng/mL of LPS for an additional 16 h. Supernatant levels of (A) TNF-α and (B) IL-10 were measured by ELISA at 17 h. Mean ± S.E.M. are shown. N = 4. *P < 0.05 vs. DMSO only. †P = 0.06 vs. DMSO only. #P<0.05 vs. 1 nM. ‡P = 0.08 vs. 1 nM. Repeated Measures ANOVA with Tukey test for post-hoc analysis.
Fig 8
Fig 8. Effect of miR-155 on cytokine production.
Monocytes were treated either with DMSO (as control) or 100 nM IκK-16 for 1 h and then transfected with scrambled RNA (sham) or miR-155 mimics or antagomirs for 16 h. Cells were then stimulated with 100 ng/mL of LPS for 6 (A & B) and 24 h (C & D). Supernatant protein levels of TNF-α and IL-10 were determined by ELISA. N = 4, Paired t-test. * P < 0.05. † p = 0.050. ‡ p = 0.090.

References

    1. Polinder S, Haagsma JA, Toet H, van Beeck EF. Epidemiological burden of minor, major and fatal trauma in a national injury pyramid. The British journal of surgery. 2012;99 Suppl 1:114–21. Epub 2012/03/28. doi: 10.1002/bjs.7708 . - DOI - PubMed
    1. Polk HC Jr., George CD, Wellhausen SR, Cost K, Davidson PR, Regan MP, et al. A systematic study of host defense processes in badly injured patients. Annals of surgery. 1986;204(3):282–99. ; PubMed Central PMCID: PMCPMC1251278. - PMC - PubMed
    1. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–90. doi: 10.1084/jem.20111354 ; PubMed Central PMCID: PMCPMC3244029. - DOI - PMC - PubMed
    1. Demetriades D, Kimbrell B, Salim A, Velmahos G, Rhee P, Preston C, et al. Trauma deaths in a mature urban trauma system: is "trimodal" distribution a valid concept? J Am Coll Surg. 2005;201(3):343–8. doi: 10.1016/j.jamcollsurg.2005.05.003 . - DOI - PubMed
    1. Galbraith N, Walker S, Galandiuk S, Gardner S, Polk HC Jr. The Significance and Challenges of Monocyte Impairment: For the Ill Patient and the Surgeon. Surgical infections. 2016;17(3):303–12. Epub 2016/03/10. doi: 10.1089/sur.2015.245 . - DOI - PubMed

LinkOut - more resources